# Insights Into Cannabis and Cannabinoids: Chemical Properties, Legal Perspectives, and Therapeutic Applications.

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-cannabinoids-therapeutic-applications-review/
> **Published:** 2026-03-18T17:42:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T15:53:54-04:00
> **Clinical Summary:** Explore cannabis cannabinoids therapeutic applications with insights into chemical properties and legal perspectives for evidence-based clinical use.

---

CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications.
Evidence Watch  |  CED Clinic
PainEpilepsyPhytochemistryEvidence-BasedReview

Journal
Chemistry & biodiversity

Study Type
Randomized Trial

Population
Human participants

Why This Matters

This comprehensive review synthesizes evidence across cannabis medicine’s core domains—phytochemistry, pharmacology, clinical applications, and regulatory frameworks. For clinicians entering [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), it provides a structured foundation for understanding the complexity of whole-plant therapeutics beyond isolated cannabinoids.

Clinical Summary

This systematic review examines over 500 identified [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) including cannabinoids, terpenes, flavonoids, and alkaloids across therapeutic domains of [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), epilepsy, oncology, psychiatry, and inflammation. The authors integrate historical use patterns, phytochemical analysis, clinical trial data, and regulatory perspectives to map current evidence. Notable limitations include acknowledgment of dosing uncertainties, long-term safety gaps, and standardization challenges that persist across [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). The review emphasizes evidence gaps requiring randomized controlled trials for evidence-based practice advancement.

Dr. Caplan’s Take

“This review accurately captures both the therapeutic promise and clinical challenges I encounter daily—we have compelling mechanistic rationale and patient outcomes, yet dosing remains more art than science. The emphasis on standardization and rigorous trial design reflects the field’s maturation toward evidence-based practice.”

Clinical Perspective
Clinicians should use this as a reference framework for understanding cannabis complexity while maintaining realistic expectations about current evidence quality. Patients benefit from understanding that cannabis medicine involves multiple active compounds with varying effects, requiring individualized approaches rather than standardized protocols.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Insights%20Into%20Cannabis%20and%20Cannabinoids%3A%20Chemical%20Properties%2C%20Legal%20Perspectives...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41822997/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41822997/)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Insights%20Into%20Cannabis%20and%20Cannabinoids%3A%20Chemical%20Properties%2C%20Legal%20Perspectives...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41822997/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41822997/](https://pubmed.ncbi.nlm.nih.gov/41822997/)

Table of Contents

- [FAQ](#FAQ)[What cannabis compounds and medical conditions does this review cover?](#What_cannabis_compounds_and_medical_conditions_does_this_review_cover)
- [Does this review address legal and regulatory aspects of cannabis?](#Does_this_review_address_legal_and_regulatory_aspects_of_cannabis)
- [What gaps or limitations in cannabis medicine does the review identify?](#What_gaps_or_limitations_in_cannabis_medicine_does_the_review_identify)
- [Related](#Related)

## FAQ

### What cannabis compounds and medical conditions does this review cover?

The review examines more than 500 identified [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/), including cannabinoids, terpenes, flavonoids and alkaloids. It looks at them across five therapeutic domains: [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), epilepsy, oncology, psychiatry and inflammation. It was published in the journal Chemistry & Biodiversity.

### Does this review address legal and regulatory aspects of cannabis?

Yes. The authors integrate regulatory perspectives together with historical use patterns, phytochemical analysis and clinical trial data. Combining these different kinds of information is how the review sets out to map the current evidence across cannabis medicine.

### What gaps or limitations in cannabis medicine does the review identify?

The review acknowledges dosing uncertainties, long-term safety gaps and standardization challenges that persist across cannabis medicine. It emphasizes that these evidence gaps require randomized controlled trials for evidence-based practice to advance.

{“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Insights Into Cannabis and Cannabinoids: Chemical Properties, Legal Perspectives, and Therapeutic Applications.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41822997/”, “about”: “chemistry biodiversity randomized trial insights into”, “isPartOf”: “Chemistry & biodiversity”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Can Cannabis Replace Opioids for Chronic Pain? A New Review Maps What We Know—and What Remains Uncertain](https://cedclinic.com/cannabinoid-analgesia-mechanisms-chronic-pain-2025/)

Explore the potential of cannabis as an alternative to opioids for [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/), highlighting current evidence and challenges.

[Read More](https://cedclinic.com/cannabinoid-analgesia-mechanisms-chronic-pain-2025/)

[Medical Cannabis for Chronic Pain: Promise, Pharmacology, and Persistent Gaps](https://cedclinic.com/medical-cannabis-chronic-pain-review-2025/)

A detailed review of medical [cannabis pharmacology](https://cedclinic.com/cannabis-tolerance-behavioral-models/) and its promise in chronic pain treatment alongside existing research gaps.

[Learn More](https://cedclinic.com/medical-cannabis-chronic-pain-review-2025/)

[Cannabinoids for Nerve Pain: What the Best Clinical Evidence Says About Sleep and Pain Relief](https://cedclinic.com/cannabinoid-therapy-neuropathic-pain-sleep-relief/)

Clinical insights into cannabinoids for neuropathic pain and their effects on sleep and pain relief.

[Discover More](https://cedclinic.com/cannabinoid-therapy-neuropathic-pain-sleep-relief/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).